ProfileGDS4718 / 216065_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 11% 23% 21% 16% 26% 20% 18% 19% 22% 22% 21% 21% 34% 14% 17% 18% 23% 17% 8% 21% 18% 21% 18% 24% 13% 20% 32% 13% 28% 19% 24% 15% 19% 22% 28% 19% 16% 20% 26% 22% 18% 24% 16% 21% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]3.8360511
GSM549102patient 115, normal, homogenized [OPG study]4.2672923
GSM549104patient 119, normal, homogenized [OPG study]4.1741721
GSM549108patient 138, normal, homogenized [OPG study]4.0434316
GSM549119patient 077, normal, homogenized [OPG study]4.3945526
GSM549133patient 032, cancer, homogenized [OPG study]4.115120
GSM549139patient 042, cancer, homogenized [OPG study]4.0461218
GSM549099patient 107, normal, homogenized [OPG study]4.1296719
GSM549109patient 139, normal, homogenized [OPG study]4.2514822
GSM549110patient 046, normal, homogenized [OPG study]4.2187522
GSM549114patient 063, normal, homogenized [OPG study]4.1387821
GSM549122patient 082, normal, homogenized [OPG study]4.2019621
GSM549134patient 033, cancer, homogenized [OPG study]4.7191234
GSM549136patient 036, cancer, homogenized [OPG study]3.879414
GSM549140patient 044, cancer, homogenized [OPG study]4.0041817
GSM549111patient 047, normal, homogenized [OPG study]4.0506618
GSM549113patient 057, normal, homogenized [OPG study]4.2047323
GSM549132patient 031, cancer, homogenized [OPG study]4.0130217
GSM549137patient 038, cancer, homogenized [OPG study]3.707558
GSM549142patient 047, cancer, homogenized [OPG study]4.2858721
GSM549100patient 110, normal, homogenized [OPG study]4.0950318
GSM549107patient 135, normal, homogenized [OPG study]4.1512621
GSM549115patient 068, normal, homogenized [OPG study]4.0220618
GSM549116patient 072, normal, homogenized [OPG study]4.2750724
GSM549120patient 078, normal, homogenized [OPG study]3.9000313
GSM549131patient 030, cancer, homogenized [OPG study]4.1068620
GSM549118patient 074, normal, homogenized [OPG study]4.6144232
GSM549129patient 027, cancer, homogenized [OPG study]3.9007613
GSM549123patient 088, normal, homogenized [OPG study]4.4505228
GSM549124patient 006, cancer, homogenized [OPG study]4.1558519
GSM549126patient 015, cancer, homogenized [OPG study]4.274324
GSM549128patient 025, cancer, homogenized [OPG study]3.9499515
GSM549103patient 117, normal, homogenized [OPG study]4.1587319
GSM549117patient 073, normal, homogenized [OPG study]4.1896922
GSM549138patient 041, cancer, homogenized [OPG study]4.4319728
GSM549141patient 045, cancer, homogenized [OPG study]4.0621519
GSM549130patient 028, cancer, homogenized [OPG study]4.0024116
GSM549101patient 111, normal, homogenized [OPG study]4.1650720
GSM549105patient 128, normal, homogenized [OPG study]4.4017126
GSM549106patient 134, normal, homogenized [OPG study]4.1548622
GSM549112patient 048, normal, homogenized [OPG study]4.0688518
GSM549125patient 011, cancer, homogenized [OPG study]4.2942824
GSM549127patient 024, cancer, homogenized [OPG study]3.9684616
GSM549135patient 035, cancer, homogenized [OPG study]4.1339221